Right Turn: Phacilitate’s Advanced Therapies Week 2023 offers “reasons to be cheerful”

Last year saw the organizers behind Advanced Therapies Week (ATW) move the conference from Miami to Miami Beach to accommodate a larger audience. As the Covid-19 pandemic was still going strong in January 2022, making international travel more difficult, attendance was lower than anticipated. In fact, on-site testing resulted in some delegates being turned away...

Continue reading


Regenerating a degenerative joint: MSCs as treatment for osteoarthritis

Source: Wiki Commons While you all know me as a writer for Signals, I actually spend most of time working clinically. When wearing my health-care provider hat as a physician assistant in orthopaedics, I’m often asked about the use of stem cell therapy for the treatment of arthritis. Beyond the fact that stem cell therapy...

Continue reading


ARM’s “State of the Industry” update: Keeping up with the speed of science

The Alliance for Regenerative Medicine (ARM) delivered its State of the Industry Briefing (#CGSOTI23) at Biotech Showcase, held January 9–11, 2023, in San Francisco, California. Tim Hunt, CEO, of the Alliance for Regenerative Medicine (ARM) kicked things off by outlining ARM’s role in convening the regenerative medicine (RM) sector. He spoke of ARM’s efforts to...

Continue reading


2022 UK cell and gene therapy ecosystem highlights

In 2022, the UK’s Cell and Gene Therapy Catapult (aka CGT Catapult) celebrated its tenth anniversary (congratulations!) marking 10 years of accelerating innovation in cell and gene therapies (CGTs) in the UK. Much like CCRM, CGT Catapult was established as an ecosystem-building organization. CGT Catapult was founded with the mission to grow a viable and...

Continue reading


Right Turn: Favourite blog posts of 2022

Having written several “my favourite blog posts” over the years, I decided to turn this very important responsibility over to my communications colleagues at CCRM. I asked Cal Strode and Tannen Horber, who are both contributors and have bios on the site, to pick their favourite posts and explain their choices. Cal Strode’s top Signals...

Continue reading


Right Turn: Lupus’ moment

Back in 2014, Selena Gomez was diagnosed with lupus. The singer and actress has been public about getting chemotherapy to treat her condition, and her kidney transplant. The autoimmune disease causes the immune system to attack the body’s tissues and organs. Inflammation caused by lupus can affect joints, skin, kidneys, blood cells, the brain, heart...

Continue reading


Having the right country alliances is key for internationalization efforts: South Korea

Bhavi Kadakia was an intern with CCRM Australia in 2020 and is currently employed at Novotech. The Asia Pacific region has 453 developers, up 10 per cent from 2021. Image: Alliance for Regenerative Medicine H1 2022 (September) report In the health-care sector, translation and commercialization have traditionally been described as complex and requiring heavy investment....

Continue reading


Right Turn: Experts weigh in on manufacturing of CGTs at JLABS-CCRM event

If manufacturing is the gatekeeper to success in the cell and gene therapy space, it’s not surprising that the topic regularly comes up when industry leaders come together to discuss the future or to tackle the challenges we face in commercializing cell and gene therapies (CGTs). Such was the case earlier this month at the...

Continue reading